Literature DB >> 18177784

New algorithm for treatment allocation reduced selection bias and loss of power in small trials.

J Hofmeijer1, P C Anema, I van der Tweel.   

Abstract

OBJECTIVE: In clinical trials, patients become available for treatment sequentially. Especially in trials with a small number of patients, loss of power may become an important issue, if treatments are not allocated equally or if prognostic factors differ between the treatment groups. We present a new algorithm for sequential allocation of two treatments in small clinical trials, which is concerned with the reduction of both selection bias and imbalance. STUDY DESIGN AND
SETTING: With the algorithm, an element of chance is added to the treatment as allocated by minimization. The amount of chance depends on the actual amount of imbalance of treatment allocations of the patients already enrolled. The sensitivity to imbalance may be tuned. We performed trial simulations with different numbers of patients and prognostic factors, in which we quantified loss of power and selection bias.
RESULTS: With our method, selection bias is smaller than with minimization, and loss of power is lower than with pure randomization or treatment allocation according to a biased coin principle.
CONCLUSION: Our method combines the conflicting aims of reduction of bias by predictability and reduction of loss of power, as a result of imbalance. The method may be of use in small trials.

Entities:  

Mesh:

Year:  2007        PMID: 18177784     DOI: 10.1016/j.jclinepi.2007.04.002

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  10 in total

1.  Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization.

Authors:  Jody Ciolino; Wenle Zhao; Renee' Martin; Yuko Palesch
Journal:  Contemp Clin Trials       Date:  2010-11-13       Impact factor: 2.226

2.  The effects of a cardiac rehabilitation program tailored for women on their perceptions of health: a randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Jan-Feb       Impact factor: 2.081

3.  Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.

Authors:  Adnan I Qureshi; Foad Abd-Allah; Aitziber Aleu; John J Connors; Ricardo A Hanel; Ameer E Hassan; Haitham M Hussein; Nazli A Janjua; Rakesh Khatri; Jawad F Kirmani; Mikael Mazighi; Heinrich P Mattle; Jefferson T Miley; Thanh N Nguyen; Gustavo J Rodriguez; Qaisar A Shah; Adnan H Siddiqui; Jose I Suarez; M Fareed K Suri; Reha Tolun
Journal:  J Vasc Interv Neurol       Date:  2014-05

4.  The effects of a cardiac rehabilitation program tailored for women on global quality of life: a randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Womens Health (Larchmt)       Date:  2010-09-16       Impact factor: 2.681

5.  Statistical issues in the use of dynamic allocation methods for balancing baseline covariates.

Authors:  G R Pond
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

6.  Internet-based treatment for Romanian adults with panic disorder: protocol of a randomized controlled trial comparing a Skype-guided with an unguided self-help intervention (the PAXPD study).

Authors:  Amalia Maria Ciuca; Thomas Berger; Liviu George Crişan; Mircea Miclea
Journal:  BMC Psychiatry       Date:  2016-01-14       Impact factor: 3.630

7.  Covariate-constrained randomization for cluster randomized trials in the long-term care setting: Application to the TRAIN-AD trial.

Authors:  Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  Contemp Clin Trials Commun       Date:  2020-03-17

Review 8.  Allocation techniques for balance at baseline in cluster randomized trials: a methodological review.

Authors:  Noah M Ivers; Ilana J Halperin; Jan Barnsley; Jeremy M Grimshaw; Baiju R Shah; Karen Tu; Ross Upshur; Merrick Zwarenstein
Journal:  Trials       Date:  2012-08-01       Impact factor: 2.279

9.  VAST: Vertebral Artery Stenting Trial. Protocol for a randomised safety and feasibility trial.

Authors:  A Compter; H B van der Worp; W J Schonewille; J A Vos; A Algra; T H Lo; W P Th M Mali; F L Moll; L J Kappelle
Journal:  Trials       Date:  2008-11-24       Impact factor: 2.279

10.  Intervention versus standard medical treatment in patients with symptomatic occlusion of the internal carotid artery: a randomised oxygen-15 PET study.

Authors:  Suzanne Persoon; Bart Nm van Berckel; Jochem P Bremmer; Ronald Boellaard; Ale Algra; Gert Jan de Borst; Adriaan A Lammertsma; L Jaap Kappelle; Catharina Jm Klijn
Journal:  EJNMMI Res       Date:  2013-12-05       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.